Skip to search formSkip to main contentSkip to account menu

AF802

Known as: AF-802 
National Institutes of Health

Related topics

Related topics

2 relations
CH5424802

Broader (1)

alectinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Journey of the ALK-inhibitor CH5424802 to phase II clinical trial
The anaplastic lymphoma kinase (ALK) receptor tyrosine kinase represents a potential therapeutic target. Specially, a variety of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)